晶瑞电材(300655) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥450,508,527.58, representing an increase of 11.91% compared to ¥402,569,609.05 in the same period last year[5] - Net profit attributable to shareholders was ¥31,968,364.05, up 38.81% from ¥23,030,250.85 year-on-year[5] - Basic earnings per share rose to ¥0.09, a 28.57% increase from ¥0.07 in the same period last year[5] - The net cash flow from operating activities increased by 159.17%, reaching ¥56,937,551.08 compared to ¥21,969,488.68 in the previous year[5] - The company reported a significant increase in operating profit, which rose to 38,687,076.25 from 29,021,575.24, marking an increase of around 33.4%[44] - The total comprehensive income for the current period is 33,009,335.30, compared to 25,092,507.13 in the previous period, reflecting an increase of about 31.2%[44] Assets and Liabilities - Total assets at the end of Q1 2022 were ¥3,099,001,617.99, a 5.96% increase from ¥2,924,628,198.60 at the end of the previous year[7] - The total current assets at the end of the period were CNY 1,439,779,283.89, an increase from CNY 1,360,901,744.79 at the beginning of the year[31] - The total liabilities decreased to CNY 1,142,785,359.39 from CNY 1,240,570,585.85, a reduction of 7.88%[37] - The equity attributable to shareholders of the parent company increased to CNY 1,877,604,631.04 from CNY 1,606,729,586.96, reflecting a growth of 16.83%[36] Cash and Cash Equivalents - Cash and cash equivalents increased by 54.07% to ¥103,756,076.10, driven by fundraising activities[13] - The cash and cash equivalents at the end of the period were CNY 705,985,301.82, up from CNY 585,319,672.45 at the beginning of the year, representing an increase of 20.53%[31] - The company’s cash and cash equivalents at the end of the period totaled 650,941,173.73, up from 310,632,188.70, representing a growth of approximately 109.5%[48] Research and Development - The company's R&D expenses increased by 44.00% to ¥14,482,325.13 from ¥10,057,174.24 in the previous year, indicating a continued focus on innovation[13] - Research and development expenses increased to 14,482,325.13 from 10,057,174.24, reflecting a rise of approximately 43.5%[44] Shareholder Information - The top ten unrestricted shareholders hold a total of 100,000,000 shares, with the largest shareholder holding 57,567,725 shares[17] - The company issued 5,810,032 shares to specific investors, which were listed on February 7, 2022[24] - The company’s stock issuance to specific investors is subject to a six-month lock-up period[24] - The company’s stock incentive plan has specific conditions for vesting, which have been met for the first batch of shares[21] - The company has not disclosed any related party relationships among the top shareholders[17] Financial Expenses and Income - The company experienced a 66.99% increase in taxes and surcharges, totaling ¥2,469,734.59, primarily due to increased revenue[9] - The company’s financial expenses increased to 4,543,703.94 from 3,793,662.33, which is an increase of approximately 19.7%[44] - The company raised 244,024,355.84 in cash from investment activities, indicating a strong capital inflow compared to the previous period[48] Stock and Incentive Plans - The company completed the first batch of the second phase of the restricted stock incentive plan, with shares listed on March 24, 2022[21] - The company announced the resignation of its financial director and board secretary, which led to the cancellation of 770,060 shares from the incentive plan[23] - The company approved a comprehensive credit limit application and provided collateral guarantees during the board meeting on March 10, 2022[26] - The company’s board and supervisory board underwent a re-election process, with new members appointed on March 28, 2022[25]